Research
Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise
Holger J. Schünemann, Wojtek Wiercioch, Itziar Etxeandia, Maicon Falavigna, Nancy Santesso, Reem Mustafa, Matthew Ventresca, Romina Brignardello-Petersen, Kaja-Triin Laisaar, Sérgio Kowalski, Tejan Baldeh, Yuan Zhang, Ulla Raid, Ignacio Neumann, Susan L. Norris, Judith Thornton, Robin Harbour, Shaun Treweek, Gordon Guyatt, Pablo Alonso-Coello, Marge Reinap, Jan Brožek, Andrew Oxman and Elie A. Akl
CMAJ February 18, 2014 186 (3) E123-E142; DOI: https://doi.org/10.1503/cmaj.131237
Holger J. Schünemann
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
MD PhDWojtek Wiercioch
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
BHScItziar Etxeandia
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
Pharm DMaicon Falavigna
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
MD PhDNancy Santesso
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
MLISReem Mustafa
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
MD MPHMatthew Ventresca
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
BHScRomina Brignardello-Petersen
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
DDMKaja-Triin Laisaar
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
MD MPHSérgio Kowalski
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
MD PhDTejan Baldeh
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
Yuan Zhang
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
BHScUlla Raid
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
PhDIgnacio Neumann
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
MDSusan L. Norris
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
MD MPHJudith Thornton
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
PhDRobin Harbour
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
BScShaun Treweek
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
PhDGordon Guyatt
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
MD MSPablo Alonso-Coello
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
MD PhDMarge Reinap
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
MAJan Brožek
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
MDAndrew Oxman
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
MD MSElie A. Akl
Department of Clinical Epidemiology and Biostatistics (Schünemann, Wiercioch, Etxeandia, Falavigna, Santesso, Mustafa, Ventresca, Kowalski, Baldeh, Zhang, Neumann, Guyatt, Brožek, Akl) and Department of Medicine (Schünemann, Brošek, Guyatt), McMaster University, Hamilton, Ont.; Department für Medizinische Biometrie und Medizinische Informatik (Schünemann, Brošek), Universitätsklinikum Freiburg, Freiburg, Germany; Department of Community Health Sciences (Ventresca), Brock University, St. Catharines, Ont.; Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon; Department of Medicine (Akl), University at Buffalo, New York State University, Buffalo, NY; Department of Internal Medicine and Nephrology (Mustafa), University of Missouri–Kansas City, Kansas City, Mo.; Oregon Health and Science University (Norris), Portland, Ore.; National Institute of Science and Technology for Health Technology Assessment (Falavigna), Federal University of Rio Grande do Sul, and Hospital Moinhos de Ventos, Porto Alegre, Brazil; Department of Internal Medicine (Neumann), Pontificia Universidad Católica de Chile, Santiago, Chile; Estonian Health Insurance Fund (Raid), Estonian Country Office of the World Health Organization (Reinap), Tallinn, Estonia; University of Tartu (Laisaar), Tartu, Estonia; University of Aberdeen (Treweek), Aberdeen, UK; National Institute for Health and Care Excellence (Thornton), London, UK; Scottish Intercollegiate Guideline Network (Harbour), Healthcare Improvement Scotland, Edinburgh, UK; Institute of Health Policy, Management and Evaluation (Brignardello-Petersen), University of Toronto, Toronto, Ont.; Faculty of Dentistry (Brignardello-Petersen), University of Chile, Santiago, Chile; and Norwegian Knowledge Center for the Health Services (Oxman), Oslo, Norway
MD PhD
Data supplements
Online Appendix
GIN-McMaster Guideline Development Checklist - French Translation
GIN-McMaster Guideline Development Checklist - French Translation
Related Articles
- (2014). Highlights. CMAJ, 186(3), 159. Accessed September 25, 2023. Retrieved from http://www.cmaj.ca/content/186/3/159.
In this issue
Article tools
Respond to this article
Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise
Holger J. Schünemann, Wojtek Wiercioch, Itziar Etxeandia, Maicon Falavigna, Nancy Santesso, Reem Mustafa, Matthew Ventresca, Romina Brignardello-Petersen, Kaja-Triin Laisaar, Sérgio Kowalski, Tejan Baldeh, Yuan Zhang, Ulla Raid, Ignacio Neumann, Susan L. Norris, Judith Thornton, Robin Harbour, Shaun Treweek, Gordon Guyatt, Pablo Alonso-Coello, Marge Reinap, Jan Brožek, Andrew Oxman, Elie A. Akl
CMAJ Feb 2014, 186 (3) E123-E142; DOI: 10.1503/cmaj.131237
Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise
Holger J. Schünemann, Wojtek Wiercioch, Itziar Etxeandia, Maicon Falavigna, Nancy Santesso, Reem Mustafa, Matthew Ventresca, Romina Brignardello-Petersen, Kaja-Triin Laisaar, Sérgio Kowalski, Tejan Baldeh, Yuan Zhang, Ulla Raid, Ignacio Neumann, Susan L. Norris, Judith Thornton, Robin Harbour, Shaun Treweek, Gordon Guyatt, Pablo Alonso-Coello, Marge Reinap, Jan Brožek, Andrew Oxman, Elie A. Akl
CMAJ Feb 2014, 186 (3) E123-E142; DOI: 10.1503/cmaj.131237
Jump to section
Related Articles
Cited By...
- Methods used to select results to include in meta-analyses of nutrition research: a meta-research study
- Clinical practice guideline adaptation methods in resource-constrained settings: four case studies from South Africa
- Recommandations canadiennes pour les pratiques optimales de prise en charge de la sclerose laterale amyotrophique
- Canadian best practice recommendations for the management of amyotrophic lateral sclerosis
- Going "the Last Mile" With Guidelines for Deferred Umbilical Cord Clamping
- Financial conflict of interest among clinical practice guideline-producing organisations
- Assessing the process and outcome of the development of practice guidelines and recommendations: PANELVIEW instrument development
- Diagnosing acute aortic syndrome: a Canadian clinical practice guideline
- 'Building on shaky ground--challenges to and solutions for primary care guideline implementation in four provinces in South Africa: a qualitative study
- Management of the neurologically deceased organ donor: A Canadian clinical practice guideline
- Extending the RIGHT statement for reporting adapted practice guidelines in healthcare: the RIGHT-Ad@pt Checklist protocol
- Reporting, presentation and wording of recommendations in clinical practice guideline for gout: a systematic analysis
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism
- American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
- Strengthening the quality of paediatric primary care: protocol for the process evaluation of a health systems intervention in South Africa
- PACK Child: the development of a practical guide to extend the scope of integrated primary care for children and young adolescents
- A systematic review of how patients value COPD outcomes
- Choosing guidelines to use in your practice
- Choisir les guides de pratique clinique a utiliser
- Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline
- Deprescription des agonistes des recepteurs des benzodiazepines: Lignes directrices de pratique clinique fondees sur les donnees probantes
- Deprescription des antipsychotiques pour les symptomes comportementaux et psychologiques de la demence et linsomnie: Guide de pratique clinique fonde sur des donnees probantes
- Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline
- Deprescribing antihyperglycemic agents in older persons: Evidence-based clinical practice guideline
- Deprescription des antihyperglycemiants chez les personnes agees: Guide de pratique clinique fonde sur les donnees probantes
- Perspective: Improving Nutritional Guidelines for Sustainable Health Policies: Current Status and Perspectives
- Deprescrire les inhibiteurs de la pompe a protons: Lignes directrices de pratique clinique fondees sur les donnees probantes
- Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline
- World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update
- The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in medical and critically ill patients
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines
- Do "Evidence-Based Recommendations" Need to Reveal the Evidence? Minimal Criteria Supporting an "Evidence Claim"
- The development of guideline implementation tools: a qualitative study
- Do guidelines offer implementation advice to target users? A systematic review of guideline applicability
More in this TOC Section
Similar Articles
Collections
